Merck Acquires License for Experimental Skin-Patch Immunization

Merck & Co., the maker of the Gardasil cervical cancer vaccine, will work with Vaxxas Pty to develop a skin-patch delivery system for immunizations, the Brisbane, Australia-based company said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.